Mammalian target of rapamycin (mTOR) inhibitors as anti-cancer agents.

Rao, Ravi D; Buckner, Jan C; Sarkaria, Jann N

Rao, Ravi D; Buckner, Jan C; Sarkaria, Jann N.

Affiliation

Rao RD; Department of Oncology, Mayo Clinic College of Medicine, 200 First St. SW, Rochester, MN 55905, USA.

Curr Cancer Drug Targets ; 4(8): 621-35, 2004 Dec.

Article in En | MEDLINE | ID: mdl-15578919

Subject(s)

Antineoplastic Agents/therapeutic use; Neoplasms/drug therapy; Protein Kinases/metabolism; Sirolimus/therapeutic use; Animals; Humans; Neoplasms/metabolism; Neoplasms/pathology; Protein Kinase Inhibitors/therapeutic use; Sirolimus/analogs & derivatives; TOR Serine-Threonine Kinases

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Protein Kinases / Sirolimus / Neoplasms / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Curr Cancer Drug Targets Journal subject: ANTINEOPLASICOS / NEOPLASIAS Year: 2004 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links